# T-GENVIH-003 LTFU (Long Term Follow Up) Study

> **NCT06034652** · — · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 8 (actual)

## Conditions studied

- Hernia
- Hernia, Ventral
- Pathological Conditions, Anatomical
- Hernia, Abdominal

## Interventions

- **DEVICE:** Integra® Gentrix® Surgical Matrix

## Key facts

- **NCT ID:** NCT06034652
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-12
- **Primary completion:** 2024-01-19
- **Final completion:** 2024-01-19
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034652, "T-GENVIH-003 LTFU (Long Term Follow Up) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06034652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*